Abstract |
Oxaliplatin is effective when used with 5-fluorouracil (5-FU) and leucovorin, or with capecitabine (COX) for the treatment of colorectal cancer. In this experiment, we investigated the optimal combination schedule and antitumor activity of oral S-1 with oxaliplatin combination therapy (SOX) against human colorectal cancer xenografts in vivo. Using human colon cancer COL-1-bearing nude mice, oxaliplatin was administered at a total dose of 8.3 mg/kg on day 1 alone, on day 8 alone, or in divided doses administered on days 1 and 8 with S-1 (6.9 mg/kg, days 1-14). The antitumor activity of SOX, administered according to the divided schedule was significantly superior to both monotherapies (p<0.01), and the toxicity was tolerable. However, administration on day 8 alone failed to significantly increase the antitumor activity, when compared with that of monotherapy, while administration on day 1 alone was toxic in this model. Next, the efficacy of SOX was compared with that of COX (360 mg/kg, days 1-14). The antitumor effect of SOX was significantly superior to that of COX (p<0.01), with an equivalent toxicity; moreover SOX suppressed COL-1 tumor growth for a longer period of time (2.2 times) than did COX. The antitumor activity of SOX against the 5-FU-resistant colorectal cancer cell line KM12C/5-FU was equivalent to that of COX. The evaluation of intermittent SOX administration in a clinical trial might be of critical value.
|
Authors | Mamoru Nukatsuka, Hitoshi Saito, Kazuki Sakamoto, Fumio Nakagawa, Junji Uchida, Takashi Kobunai, Kazuyoshi Shiraishi, Teiji Takechi |
Journal | Anticancer research
(Anticancer Res)
Vol. 32
Issue 7
Pg. 2807-12
(Jul 2012)
ISSN: 1791-7530 [Electronic] Greece |
PMID | 22753741
(Publication Type: Journal Article)
|
Chemical References |
- Drug Combinations
- Organoplatinum Compounds
- Oxaliplatin
- Deoxycytidine
- S 1 (combination)
- Tegafur
- Oxonic Acid
- Capecitabine
- Fluorouracil
|
Topics |
- Animals
- Antineoplastic Combined Chemotherapy Protocols
(pharmacology)
- Capecitabine
- Colorectal Neoplasms
(drug therapy)
- Deoxycytidine
(administration & dosage, analogs & derivatives)
- Drug Administration Schedule
- Drug Combinations
- Drug Resistance, Neoplasm
- Fluorouracil
(administration & dosage, analogs & derivatives, pharmacology)
- Humans
- Male
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Organoplatinum Compounds
(administration & dosage)
- Oxaliplatin
- Oxonic Acid
(administration & dosage)
- Tegafur
(administration & dosage)
- Xenograft Model Antitumor Assays
|